Tsuzuki S, Yasuda T, Goto H, Maeda N, Akahane K, Inukai T, Yamamoto H, Karnan S, Ota A, Hyodo T, Konishi H, Hosokawa Y, Kiyoi H, Hayakawa F. BCL6 inhibition ameliorates resistance to ruxolitinib in <i>CRLF2</i&gt;-rearranged acute lymphoblastic leukemia. Haematologica 2023;108(2):394-408; https://doi.org/10.3324/haematol.2022.280879.